TRAVERE THERAPEUTICS INC's ticker is and the CUSIP is 89422GAA5. A total of 26 filers reported holding TRAVERE THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $1,599,000 | – | 1,599 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Context Capital Management, LLC | 29,167 | $23,461 | 2.12% |
| BRAIDWELL LP | 28,350,000 | $22,804,031 | 0.74% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 25,000,000 | $20,400,886 | 0.64% |
| READYSTATE ASSET MANAGEMENT LP | 9,000,000 | $7,239,375 | 0.54% |
| WOLVERINE ASSET MANAGEMENT LLC | 45,400,000 | $36,908,513 | 0.44% |
| Segantii Capital Management Ltd | 8,000,000 | $6,566,960 | 0.34% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 7,000,000 | $5,700,520 | 0.25% |
| CAPSTONE INVESTMENT ADVISORS, LLC | 44,393,000 | $35,708,619 | 0.18% |
| LINDEN ADVISORS LP | 13,993,000 | $11,365,814 | 0.12% |
| AVIVA PLC | 18,000,000 | $14,728,950 | 0.06% |